The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder

被引：0
|
作者：
Na, Kyoungsae [1 ]
Jung, Han-Yong [2 ]
机构：
[1] Gachon Univ, Gil Med Ctr, Songnam, South Korea
[2] Sooncheonhyang Univ, Bucheon Hosp, Asan, South Korea
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PM395
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [21] CHQ and CGAS in an open-label study of ziprasidone in pediatric patients with bipolar disorder, schizophrenia, or schizoaffective disorder
    DelBello, Melissa
    Stewart, Michelle
    Versavel, Mark
    Keller, David
    Miceli, Jeffrey
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (06) : 662 - 662
  • [22] Effects of oral ziprasidone and risperidone on cognitive functioning in patients with schizophrenia or schizoaffective disorder: Preliminary data
    Mitchell, D
    Hagger, C
    Wise, AL
    Schulz, SC
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 116 - 116
  • [23] Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia
    Weiden, PJ
    Simpson, GM
    Potkin, SG
    O'Sullivan, RL
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (05) : 580 - 588
  • [24] Effect of ziprasidone dose on rates of medication discontinuation in acute schizophrenia or schizoaffective disorder
    Citrome, Leslie
    Yang, Ruoyong
    Harnett, James
    Glue, Paul
    Karayal, Onur
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 285S - 285S
  • [25] Effect of ziprasidone dose on rates of medication discontinuation in acute schizophrenia or schizoaffective disorder
    Karayal, O.
    Citrome, L.
    Yang, R.
    Harnett, J.
    Glue, P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 160 - 160
  • [26] Tolerability of Oral Ziprasidone in Children and Adolescents with Bipolar Mania, Schizophrenia, or Schizoaffective Disorder
    DelBello, Melissa P.
    Versavel, Mark
    Ice, Kathleen
    Keller, David
    Miceli, Jeffrey
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (05) : 491 - 499
  • [27] Ziprasidone and risperldone equally efficacious for treatment of acute exacerbation of schizophrenia or schizoaffective disorder
    不详
    FORMULARY, 2005, 40 (03) : 92 - 93
  • [28] Effectiveness and Tolerability of Oral Ziprasidone in Psychiatric Inpatients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: A Multicenter, Prospective, and Naturalistic Study
    Diaz-Marsa, Marina
    Sanchez, Sara
    Rico-Villademoros, Fernando
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (04) : 509 - 517
  • [29] An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder
    Goff, DC
    Posever, T
    Herz, L
    Simmons, J
    Kletti, N
    Lapierre, K
    Wilner, KD
    Law, CG
    Ko, GN
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (04) : 296 - 304
  • [30] ZIPRASIDONE AS ADJUNCTIVE THERAPY IN PATIENTS WITH SCHIZOAFFECTIVE OR BIPOLAR DISORDER TREATED WITH CLOZAPINE
    Benvenuti, A.
    Lattanzi, L.
    Bartolommei, N.
    Luchini, F.
    Cosentino, L.
    Mauri, M.
    EUROPEAN PSYCHIATRY, 2012, 27
12345